Part I of the series of Ar Events under the motto “Roots of AI” was about the past – the history of artificial intelligence". Now, the “Creative Directors” and the invited speakers of Part II of the series, which took place at the Champalimaud Foundation (CF) last month, undertook to discuss the now of AI, sharing their views on the pros and cons of the technology. Part III (the last event of the series) will take place on May 7th and will deal with the future of AI.

Reported today in Science, the researchers found that mice given a diet rich in vitamin D had better immune resistance to experimentally transplanted cancers and improved responses to immunotherapy treatment. This effect was also seen when gene editing was used to remove a protein that binds to vitamin D in the blood and keeps it away from tissues.

Host

Carlos Minutti, Principal Investigator, Champalimaud Research

Venue

Seminar room

Do you know all about Non-Melanoma Skin Cancer (NMSC)?

We are thrilled to announce that the registrations for the NMSC Symposium “Non-Melanoma Skin Cancer. What do we know?”, hosted by the Champalimaud Foundation on the 7th of June, are now open!

This event will be a fusion of clinical expertise and research advancements, bringing together experts and healthcare professionals to discuss the latest research findings and clinical developments in the diagnosis and treatment of Non-Melanoma Skin Cancer.

There are varying degrees in the response of a cancerous tumour to a treatment. A complete response corresponds to the disappearance of all detectable signs of cancer in the body, while a partial or incomplete response is a decrease in the size of the tumour or in the amount of cancer in the body. To be considered a partial response, the measurable size of the tumor has to be reduced by at least 30% to 50% due to the treatment.